Blackstone bets $1.5B on Pfizer’s obesity drug
BioPharma DiveJonathan GardnerNovember 12, 2026
The deal will support a sprawling Phase 3 program for a monthly GLP-1 shot Pfizer acquired by winning a bidding war for the drug s previous owner, Metsera.